EuroJect®: Biologic Delivery Device - Part 2: Advanced Performance

6

February

  • 3PM London 10am New York
  • Free
  • Why attend?
  • Speakers
  • Contact Us

Why attend?

Join us for the second installment of our EuroJect® webinar series, where we delve deeper into the advanced capabilities and complementary performance tests of EuroJect®. Discover how this innovative platform continues to outperform traditional glass syringes and multidose vials, setting new standards in biologic delivery.

What you’ll learn:

 

  • Euroject® innovating device: different applications
  • Complementary performance tests: Explore our rigorous validation processes, including water tests that confirm precise dosing up to 2.5 ml and ensure optimal performance.
  • Extreme conditions? See how EuroJect® maintains dose integrity even at ultra-low temperatures of -80°C, safeguarding the efficacy of sensitive biologics.

 

Expert insight:

  • Mr. Fontayne returns to guide you through these advanced features, showcasing how EuroJect® is setting a new benchmark for safety, reliability, and efficiency in biologic administration.
  • Don’t miss this opportunity to expand your knowledge and stay at the forefront of therapeutic innovation. Register now to secure your place!

 

Objectives:

  • Understand the innovative application of blow-fill-seal technology in Euroject® and its significance for single-dose therapeutic injection.
  • Performance testing: Understand how EuroJect® ensures precise dosing up to 2.5 ml with rigorous validation processes.

 

Cold Storage: Discover how EuroJect® maintains dose integrity at -80°C for sensitive biologics.

Speakers

Select a speaker to learn more

Back
Elisabeth ALIDOU
Communications Manager

Elisabeth Alidou, Communications Manager at Unither Pharmaceuticals, holds a Master’s in International and Intercultural Communications from ISCOM Paris. With over 8 years of experience in the pharmaceutical sector, she specializes in digital strategies, event planning, and public relations. She is also the author of a thesis on Virtual Reality and 360-degree video, examining its accessibility, impact, and applications—from gaming to phobia treatment—reflecting her interest in innovative technologies and their societal impact.

Next speaker
Back
Alexandre FONTAYNE
CSO for biological products, Unither Pharmaceuticals

Alexandre Fontayne received his PhD in Biological Science at the University of Paris Sud (France). He has 20 years of experience in R&D, including 15 years in the pharmaceutical industry working around drug design and the production of biologics, including ublituximab. Mr Fontayne is the co-author of 28 scientific articles and inventor of 12 patents. He contributes to the training of students and employees in drug design, chemistry manufacturing and control activities and subcontracting. Since 2021, Mr Fontayne has worked for Unither Pharmaceuticals as Chief Scientific Officer for biological products, and is deeply involved in the development of the Euroject® device

Next speaker
Back
Nourhene ESSEGHIR SEGHAIER
Development Projects Manager

Nourhène Esseghir is a Development Projects Manager at Unither Pharmaceuticals, leading project development since May 2022. With a robust background in pharmaceutical formulation and development, she has held managerial roles at a variety of companies in France. Ms Esseghir’s expertise includes establishing formulation laboratories, project piloting and creating strategic partnerships. She holds a master’s degree in Pharmaceutical Technology from Université Paris Cité (Paris, France) and a doctorate in Pharmacy from Faculté de Pharmacie de Monastir (Tunisia). Passionate about advancing pharmaceutical innovations, she uses her analytical skills and industry experience to improve patient outcomes.

Next speaker

Enquiry